Search results
Bio-Techne Third Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 2 hours agoBio-Techne (NASDAQ:TECH) Third Quarter 2024 Results Key Financial Results Revenue: US$303.4m (up...
Q32 Bio: Q1 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 14 minutes agoWALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Q32 Bio Inc. (QTTB) on Thursday reported earnings of $1 million in its first quarter. The Waltham, Massachusetts-based company ...
Wedbush Comments on Gossamer Bio, Inc.’s Q2 2024 Earnings (NASDAQ:GOSS)
ETF DAILY NEWS· 4 hours agoGossamer Bio, Inc. (NASDAQ:GOSS – Free Report) – Wedbush lifted their Q2 2024 EPS estimates for Gossamer Bio in a research report issued on Monday, May ...
Regenex Bio eyes FDA meeting to confirm pivotal DMD trial
Clinical Trials Arena via Yahoo Finance· 1 hour agoRegenex Bio has announced it is meeting with the US Food and Drug Administration (FDA) with plans to...
Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down
Zacks via Yahoo Finance· 20 hours agoBio-Rad's (BIO) Clinical Diagnostics arm registers growth in Q1, primarily driven by an increased...
Bio-Rad Laboratories Maintains Full-Year Guide Despite Life Science Q1 Revenue Decline of 25 Percent
GenomeWeb News· 21 hours agoThis story has been updated to include additional information about Bio-Rad's Droplet Digital PCR initiatives. NEW YORK – Executives at Bio-Rad Laboratories ...
Earnings call: Bio-Rad sees decline in Q1 sales but maintains full-year outlook By Investing.com
Investing.com· 1 day agoIn the first quarter of 2024, Bio-Rad Laboratories, Inc. (NYSE: NYSE:BIO) reported a decrease in net...
2seventy bio Inc (TSVT) Q1 2024 Earnings Call Transcript Highlights: Strategic Shifts and ...
GuruFocus.com via Yahoo Finance· 5 hours agoRelease Date: May 08, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points 2seventy bio Inc (NASDAQ:TSVT ...
Annovis Bio, Inc. (NYSE:ANVS) Shares Sold by Merit Financial Group LLC
ETF DAILY NEWS· 1 day agoMerit Financial Group LLC decreased its holdings in Annovis Bio, Inc. (NYSE:ANVS – Free Report) by 46.1% in the fourth quarter, according to its most recent filing with the ...
Xylyx Bio announces exclusive license agreement with Vanderbilt University for donor organ...
WFRV 5 Green Bay· 24 hours agoBy rehabilitating donor organs deemed unfit for transplant, the xenogeneic cross-circulation platform holds potential to eliminate transplant waitlist mortality. NEW YORK, May 8, 2024 /PRNewswire ...
